SCHEMBL24710064

SCHEMBL24710064

CSC(=O)N1CCC(NC(=O)c2n[nH]cc2NC(=O)c2c(Cl)cccc2Cl)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK14 O94921 18/20 0.49
CCNY Q8ND76 18/20 0.49
CDK5 Q00535 3/20 0.46
CCNT1 O60563 2/20 0.46
CDK9 P50750 2/20 0.46
CDK5R1 Q15078 2/20 0.46
CDK4 P11802 2/20 0.44
CDK2 P24941 2/20 0.44
CASK O14936 1/20 0.44
CDKL5 O76039 1/20 0.44
CCNB2 O95067 1/20 0.44
CDK1 P06493 1/20 0.44
CCNB1 P14635 1/20 0.44
CCNA2 P20248 1/20 0.44
MAK P20794 1/20 0.44
CDK11B P21127 1/20 0.44
CCND1 P24385 1/20 0.44
CCNE1 P24864 1/20 0.44
CCND3 P30281 1/20 0.44
CLK1 P49759 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8262703 0.89 CDK14 (0.52) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL8263051 0.89 CDK14 (0.52) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL3936062 0.88 CDK14 (0.52) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL1286714 0.87 CDK5 (0.53) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL24710274 0.87 CDK14 (0.49) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL24758664 0.87 EPHX2 (0.54) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL4994733 0.86 USP2 (0.50) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL8262988 0.86 CDK14 (0.49) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL8261494 0.86 CDK14 (0.53) CDK14CCNYCDK5CCNT1CDK9
SCHEMBL13934387 0.85 CDK5 (0.48) CDK14CCNYCDK5CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022261220-A1 PROTEOLYSIS TARGETING CHIMERAS AND METHODS OF USE THEREOF UNIVERSITY OF MARYLAND, BALTIMORE (US) 2022-12-15 WO disclosed